Lisata Therapeutics, Inc. (LSTA)

3.20 -0.06 (-1.84%) USD  |  NASDAQ  |  May 07, 14:28
More

Lisata Therapeutics SG&A Expense (TTM) : 10.43M for Dec. 31, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for LSTA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Protalix Biotherapeutics, Inc. 11.68M
Agenus, Inc. 54.39M
Curis, Inc. 14.05M
LadRx Corp. 2.734M
Plus Therapeutics, Inc. 12.13M